Related Experiment Video

Updated: Mar 18, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

8.0K

Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth

María-Jesús Pérez-Pérez1, Eva-María Priego1, Oskía Bueno1

  • 1Instituto de Química Médica (IQM-CSIC) , Juan de la Cierva 3, E-28006 Madrid, Spain.

Journal of Medicinal Chemistry
|June 28, 2016
PubMed

Insights

Tubulin-destabilizing agents, like combretastatin A-4 (CA-4), target tumor vasculature. New compounds are needed to overcome CA-4

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Tumor vasculature offers unique targets for cancer therapy.
  • Tubulin-destabilizing agents, exemplified by combretastatin A-4 (CA-4), show therapeutic potential by disrupting tumor vascularization.
  • Limitations of CA-4, including chemical instability and poor solubility, necessitate the development of alternative agents.

Purpose of the Study:

  • To review classes of compounds acting similarly to CA-4.
  • To analyze the binding modes of these compounds to αβ-tubulin using recent structural data.
  • To explore strategies for improving the delivery of these vascular disrupting agents (VDAs).

Main Methods:

  • Literature review of tubulin-destabilizing agents and their mechanisms.
  • Analysis of structural complexes detailing compound binding to αβ-tubulin.
  • Examination of delivery enhancement approaches for VDAs.

Main Results:

  • Identification of diverse compound classes with CA-4-like activity.
  • Elucidation of binding interactions with αβ-tubulin for various agents.
  • Overview of methods to improve VDA pharmacokinetics and efficacy.

Conclusions:

  • Tubulin-destabilizing agents are promising vascular disrupting agents (VDAs) for cancer treatment.
  • Understanding binding modes and improving delivery are key to overcoming limitations of agents like CA-4.
  • Further development of these agents holds potential for enhanced cancer therapy.

More Related Videos

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications06:30

Author Spotlight: Purifying High-Quality Tubulin to Study Protein Dynamics and Therapeutic Applications

Published on: October 11, 2024

2.3K
Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin08:07

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

2.3K

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.8K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
6.4K
Microtubule Instability02:17

Microtubule Instability

6.1K
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
6.2K